Home NDC 0002-1200 Amyvid
Product NDC 0002-1200
11-digit product format 000021200
Labeler code 0002
Product ID 0002-1200_63e1d0b5-c634-4699-91b2-643a6e765139
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Florbetapir F 18
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Eli Lilly and Company
Application NDA202008
Marketing category NDA
Marketing start 2012-06-01
Substance FLORBETAPIR F-18
Active strength 51 mCi/mL
Pharmacologic classes Positron Emitting Activity [MoA], Radioactive Diagnostic Agent [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N202008-001 AMYVID FLORBETAPIR F-18 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 N202008-002 AMYVID FLORBETAPIR F-18 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 N202008-003 AMYVID FLORBETAPIR F-18 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 N202008-004 AMYVID FLORBETAPIR F-18 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13
Orange Book patents# Current patent rows page 1 of 1 · 8 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N202008-001 7687052 2027-04-30 U-4217 Drug substance, Drug product 2012-05-04 N202008-001 8506929 2027-04-30 U-4217 Drug substance, Drug product 2013-09-06 N202008-002 7687052 2027-04-30 U-4217 Drug substance, Drug product N202008-002 8506929 2027-04-30 U-4217 Drug substance, Drug product N202008-003 7687052 2027-04-30 U-4217 Drug substance, Drug product N202008-003 8506929 2027-04-30 U-4217 Drug substance, Drug product N202008-004 7687052 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 N202008-004 8506929 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 149 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 84e616aacf4f…2026-08-18 06:07:40 2026-07 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 5bbf6a4d5a75…
Observed Orange Book patent history# Patent history page 1 of 7 · 270 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N202008-001 7687052 2027-04-30 U-4217 Drug substance, Drug product 2012-05-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-001 8506929 2027-04-30 U-4217 Drug substance, Drug product 2013-09-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-002 7687052 2027-04-30 U-4217 Drug substance, Drug product 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-002 8506929 2027-04-30 U-4217 Drug substance, Drug product 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-003 7687052 2027-04-30 U-4217 Drug substance, Drug product 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-003 8506929 2027-04-30 U-4217 Drug substance, Drug product 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-004 7687052 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-004 8506929 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 84e616aacf4f…2026-08-18 06:07:40 2026-07 N202008-001 7687052 2027-04-30 U-4217 Drug substance, Drug product 2012-05-04 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-001 8506929 2027-04-30 U-4217 Drug substance, Drug product 2013-09-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-002 7687052 2027-04-30 U-4217 Drug substance, Drug product caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-002 8506929 2027-04-30 U-4217 Drug substance, Drug product caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-003 7687052 2027-04-30 U-4217 Drug substance, Drug product caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-003 8506929 2027-04-30 U-4217 Drug substance, Drug product caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-004 7687052 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-004 8506929 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N202008-001 7687052 2027-04-30 U-4217 Drug substance, Drug product 2012-05-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-001 8506929 2027-04-30 U-4217 Drug substance, Drug product 2013-09-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-002 7687052 2027-04-30 U-4217 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-002 8506929 2027-04-30 U-4217 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-003 7687052 2027-04-30 U-4217 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-003 8506929 2027-04-30 U-4217 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-004 7687052 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-004 8506929 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202008-001 7687052 2027-04-30 U-4217 Drug substance, Drug product 2012-05-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202008-001 8506929 2027-04-30 U-4217 Drug substance, Drug product 2013-09-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202008-002 7687052 2027-04-30 U-4217 Drug substance, Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202008-002 8506929 2027-04-30 U-4217 Drug substance, Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202008-003 7687052 2027-04-30 U-4217 Drug substance, Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202008-003 8506929 2027-04-30 U-4217 Drug substance, Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202008-004 7687052 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202008-004 8506929 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N202008-001 7687052 2027-04-30 U-4217 Drug substance, Drug product 2012-05-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202008-001 8506929 2027-04-30 U-4217 Drug substance, Drug product 2013-09-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202008-002 7687052 2027-04-30 U-4217 Drug substance, Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202008-002 8506929 2027-04-30 U-4217 Drug substance, Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202008-003 7687052 2027-04-30 U-4217 Drug substance, Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202008-003 8506929 2027-04-30 U-4217 Drug substance, Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202008-004 7687052 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202008-004 8506929 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 6a471c1ec25d…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Amyvid
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength FLORBETAPIR F-18 51 mCi/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 6W15Z5R0RU Internal UNII lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0002-1200-48 Amyvid 100 mL in 1 VIAL, MULTI-DOSE INJECTION, SOLUTION 100 25 0002-1200-48 Amyvid 1 in 1 CAN INJECTION, SOLUTION 1 25 0002-1200-50 Amyvid 50 mL in 1 VIAL, MULTI-DOSE INJECTION, SOLUTION 50 25 0002-1200-50 Amyvid 1 in 1 CAN INJECTION, SOLUTION 1 25
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0002-1200 AMYVID (FLORBETAPIR F 18) INJECTION, SOLUTION [ELI LILLY AND COMPANY] 22 Current NDC, Legacy NDC, 4 package rows 20241115_bb5a5043-0f51-11df-8a39-0800200c9a66.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0002-1200-30 00002120030 1 VIAL, MULTI-DOSE in 1 CAN (0002-1200-30) > 30 mL in 1 VIAL, MULTI-DOSE 2012-06-01 0000-00-00 No No Current 0002-1200-48 00002120048 1 VIAL, MULTI-DOSE in 1 CAN (0002-1200-48) / 100 mL in 1 VIAL, MULTI-DOSE 2023-05-22 No No Current 0002-1200-50 00002120050 1 VIAL, MULTI-DOSE in 1 CAN (0002-1200-50) / 50 mL in 1 VIAL, MULTI-DOSE 2012-06-01 0000-00-00 No No Current